| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |


*
Department of Anatomy and Cell Biology, University of Melbourne, Victoria,
Australia.
Department of Medicine (Austin and Repatriation Medical Centre),
University of Melbourne, Victoria, Australia.
Department of Physiology, University of Melbourne, Victoria,
Australia.
Correspondence to Dr. Christine Maric, Department of Anatomy and Cell Biology, University of Melbourne, Victoria, 3010, Australia. Phone: +61 3 9344 5251; Fax: +61 6 9347 5219; E-mail: c.maric{at}anatomy.unimelb.edu.au
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Previous in vivo studies from this group, using high-resolution autoradiography, demonstrated the presence of Ang II binding sites on RMIC in the inner stripe of the outer medulla (ISOM) but not in the inner medulla (IM) (9). In contrast, binding sites for BK, ET, and ANP have been localized to RMIC throughout the renal medulla (10,11,12). These findings suggested that there is a regional restriction associated with Ang II binding to RMIC in vivo. Interestingly, RMIC, despite the region of the medulla from which they originate, all have the ability to bind Ang II when cultured in an isoosmolal condition, suggesting a specific relation between osmolality and Ang II receptor binding properties and/or receptor expression.
The aim of the current study was to investigate the hypothesis that binding of Ang II to AT1A receptors on RMIC is regulated by osmolality. In an attempt to understand the possible mechanisms underlying the osmotic regulation of vasoactive peptide receptors, the study also examined the effects of osmolality on the presence of the mRNA for the AT1A receptor. We compared these results with those for BK B2 receptors, which seem not to be affected by changes in osmolality.
| Materials and Methods |
|---|
|
|
|---|
Manipulation of Medium Osmolality
RMIC were plated in 25-mm2 culture flasks at 1 x
105 cells/cm2 in culture medium RPMI 1640 (330 mOsm/kgH
2O) for 24 h. The osmolality of the media was then either kept at
330 mOsm/kgH2O or increased daily by increments of 100 mOsm/kgH
2O such that the final osmolalities (330, 630, 930, and 1230
mOsm/kgH 2O) all were reached at the same time point. The
osmolality of the media, once it reached 1230 mOsm/kgH2O, was also
decreased daily by decrements of 100 mOsm/kgH2O until isoosmolal
(330 mOsm/kgH 2O) conditions. Once the desired osmolality was
achieved, the cells were counted using a routine hemocytometer method and
their viability was assessed by Trypan blue exclusion and plated in 96-well
plates at 1 x 105 cells/cm2 at their corresponding
osmolalities. The cells were allowed 24 h to attach and then were used for
either reverse transcriptase-PCR (RT-PCR) or radiolabeled ligand binding.
The osmolality was adjusted by addition of NaCl and mannitol (the concentrations of NaCl and mannitol at particular media osmolalities were 0.08 M, 0.10 M, at 630 M mOsm/kgH2O; 0.16 M, 0.20 M, at 930 M mOsm/kgH2O; and 0.25 M, 0.30 M, at 1230 M mOsm/kgH2O).
Radiolabeled Ligand Binding Assay
After exposure to various osmotic challenges, RMIC were washed twice with a
buffer containing 10 mM Na2HPO 4, 120 mM NaCl, 26 mM
NaHCO3, 5.4 mM KCl, 5.6 mM glucose, and 5 mM ethylenediamine
tetraacetic acid (pH 7.4), osmolality 330 mOsm/kgH2 O. Cells were
then incubated with 1 µM [Sar1,Ile8] Ang II or 1
µM HPP-Hoe 140 (to detect nonspecific binding), buffer (50 mM Tris/HCl, 150
mM NaCl, 1 mM ethylenediamine tetraacetic acid, 25 mM MgCl 2, and
0.25% bovine serum albumin to detect total binding), 1 µM Losartan (to
detect AT1 receptor binding), or 1 µM PD 123319 (to detect
AT2 receptor binding), followed by addition of
125I-[Sar1, Ile8] Ang II or
125I-[HPP-Hoe 140] at a dose of 3 x 105 cpm/sample
for 1 h at room temperature. For competition binding, the cells were incubated
with [Sar1, Ile8] Ang II (10-5 to
10-11 M) or HPP-Hoe 140 (10-5 to 10-11 M) in
the presence of 125I-[Sar1, Ile8] Ang II or
125I-[HPP-Hoe 140] at a dose and time indicated above. Cells were
then washed with a buffer containing 30 mM NaCl and 10 mM Tris/HCl,
scintillation fluid was added, and bound radioactivity was measured in a
Packard TopCount (Meriden, CT).
Results are expressed as specific binding. Specific binding is defined as total binding minus nonspecific binding. Values were normalized to the final cell number counted using a hemocytometer. Results were analyzed using the GraphPad Prism software (GraphPad Software Inc., San Diego, CA), and binding constants were determined as described (13).
RT-PCR and Southern Blotting
After exposure of cultured RMIC to media of varying osmolality (as
described above), RNA was isolated using the RNeasy mini kit (Qiagen, Clifton
Hill, Victoria, Australia). RT reaction was performed on 5 µg of RNA in 100
mM KCl, 50 mM Tris-HCl (pH 8.4), 6 mM MgCl2, 10 mM dithiothereitol,
500 µM dNTP (Promega, Annandale, New South Wales, Australia), 12 µg/ml
random hexamers (Boehringer Mannheim, Castle Hill, New South Wales,
Australia), 40 units of RNasin (Promega), and AMV RT (for negative controls;
Boehringer Mannheim; 25 units) at 42°C for 1 h. Reverse transcription was
followed by PCR. Primers used for amplification of the AT1A
receptor mRNA were as follows: sense 5'TTGGAAACAGCTTGGTGGTGAT3';
antisense 5'CCAGGAAAAGAAGAAGAAAAGCAC3' corresponding to regions
130 to 152 and 736 to 759 of the rat AT1A receptor
(14). The same antisense
primer was used for amplification of the AT1B receptor, and the
sense primer was 5'CCAGCGCCACGCTGT3' corresponding to region 20 to
35 of the rat AT1B sequence
(15). The primers used for
amplification of the AT2 receptor mRNA were as follows: sense
5'GCTGATTTATGATAACTGCTTTAAAC3'; antisense
5'AGGTCCAAAGAGCCAGTCATATCTATAAGA3' corresponding to regions 49 to
74 and 313 to 342 of the rat AT2 receptor, respectively. The
primers used for amplification of the B2 receptor were as follows:
sense 5'GCCAATAACTTCGACTGGCTGTTCGGA3'; antisense
5'CTCCGTCTGGACCTCCTTG AACTTCTTCATC3', corresponding to regions 367
to 393 and 774 to 810 of the rat B2 receptor
(16). Denaturation, annealing,
and extension were carried out at 94°C, 60°C, and 72°C,
respectively, for 1 min each for 30 cycles, followed by a final extension at
72°C for 10 min. PCR products were analyzed by electrophoresis on a 1.4%
agarose gel then transferred onto Hybond N+ (Amersham,
Buckingamshire, UK) using alkali blotting in 0.4 M NaOH. The membrane was
hybridized with a corresponding 32P-labeled oligonucleotide probe
at 42°C for 2 h, washed in SSC/0.1% sodium dodecyl sulfate, and then
exposed to an x-ray film for 1 d.
Statistical Analysis
All results are expressed as mean ± SEM and were analyzed using
t test.
| Results |
|---|
|
|
|---|
Receptor Binding
RMIC cultured at 330 mOsm/kgH2O specifically bound
125I-[Sar1, Ile8] Ang II (1904 ± 85
cpm x 10-4/cell; Figure
1B). Binding of 125I-[Sar1, Ile8]
Ang II to RMIC cultured in a 630 mOsm/kgH2O culture medium was
similar to that of RMIC cultured in isoosmolal (330 mom/kgH2O)
culture medium (1754 ± 101 cpm x 10-4/cell;
Figure 1B). However, when RMIC
were cultured at 930 mOsm/kgH2O, the specific
125I-[Sar1, Ile8] Ang II binding was reduced
(924 ± 74 cpm x 10-4/cell; P < 0.01;
Figure 1B). Further increases
in osmolality to 1230 mOsm/kgH2O reduced specific
125I-[Sar1, Ile8] Ang II binding even further
(591 ± 90 cpm x 10-4/cell; P < 0.05;
Figure 1B). A gradual decrease
in osmolality of the culture media from 1230 mOsm/kgH2O to 330
mOsm/kgH2O restored the ability of RMIC to bind
125I-[Sar1, Ile8] Ang II (1929 ± 92
cpm x 10-4/cell; Figure
1B). Ang II competition binding revealed a gradual increase in
Kd (suggesting a gradual decrease in receptor affinity)
and Bmax (suggesting an increase in receptor binding
sites) (Figure 1A,
Table 1). Binding of
125I-[Sar1, Ile8] Ang II was completely
abolished in the presence of losartan (the AT1 receptor antagonist)
and was not affected in the presence of PD 123319 (the AT2 receptor
antagonist), suggesting that 125I-[Sar1,
Ile8] Ang II bound to AT1 receptors (data not
presented).
|
|
At 330 mOsm/kgH2O, the specific binding of 125I-[HPP-Hoe 140] to RMIC was 595.0 ± 61.0 cpm x 10-4/cell (Figure 2B). Further increases in medium osmolality from 630, 930, and 1230 mOsm/kgH2O did not influence 125I-[HPP-Hoe 140] binding to RMIC (592.0 ± 61.0 cpm x 10-4/cell; 529.0 ± 31.0 cpm x 10-4/cell; 498.5 ± 17.5 cpm x 10-4/cell, respectively; Figure 2B). Changes in osmolality did not significantly affect Kd or Bmax values, as revealed by BK competition binding (Figure 2A, Table 1).
|
RT-PCR
A PCR product of 770 bp, corresponding to the AT1A receptor
mRNA, was detected in RMIC cultured under isoosmolal conditions (330
mOsm/kgH2O; Figure
3A). Bands of the same size were also detected in RMIC cultured at
630, 930, and 1230 mOsm/kgH2O
(Figure 3A). A 710-bp band,
corresponding to the BK B2 receptor mRNA, was detected in RMIC
grown under isoosmolal conditions (Figure
3B). This PCR product was also observed in RMIC grown in media of
630, 930, and 1230 mOsm/kgH2O
(Figure 3B). No PCR products
were observed using primers for AT1B or AT2 receptors in
RMIC following osmotic challenges (data not shown).
|
| Discussion |
|---|
|
|
|---|
The hypothesis of the current study is based on two previous observations. First is that there is a regional restriction of Ang II binding to RMIC in the kidney, likely to be a consequence of changes in local environmental factors. Second is that in vitro, RMIC all possess Ang II receptors regardless of the region of origin.
High-resolution autoradiographic localization of vasoactive peptide receptors in the kidney has verified that Ang II binding sites are located on RMIC (9). Furthermore, Ang II binding is restricted to RMIC of the ISOM, whereas no significant binding capacity is observed in the IM under normal physiologic conditions (9). In contrast, BK, ET, and ANP receptors are commonly found to coexist in various cell types throughout the renal cortex and medulla (10,11,12). The somewhat restricted medullary distribution of Ang II receptors may relate to local environmental factors such as local concentrations of Ang II and/or osmolality of the interstitium. After chronic salt loading or administration of angiotensin-converting enzyme inhibitors, both of which decrease intrarenal Ang II levels, increases in in vivo labeling of Ang II receptors in the ISOM have been observed (18). However, binding of Ang II was still restricted to RMIC in the ISOM, indicating that it was unlikely that local Ang II levels were involved in changing the distribution of binding. An alternative explanation for the restricted distribution of Ang II binding therefore could be the presence of wide variations in interstitial osmolality.
Our previous studies were performed on cells isolated from whole renal medullae and therefore included cells that originated from both isoosmolal ISOM and hyperosmolal IM. Because Ang II binding studies in fresh tissue have shown no significant Ang II binding in hypersomolal areas of the IM, the majority of those cells in culture would not be expected to have Ang II receptors. Interestingly, all RMIC in culture displayed Ang II binding capacity and changes in cell function when challenged with Ang II. Collectively, these studies support the view that osmolality of the surrounding fluid is a determinant of receptor expression and function, providing a potentially important regulatory mechanism for the actions of Ang II on renal medullary function.
In the present study, gradual increases in osmolality of the culture medium resulted in progressive decreases in Ang II binding to AT1A receptors in RMIC. This change was reversible as the capacity of the receptors to bind to its ligand was restored with reversal of the osmolality to isoosmolal level. This phenomenon seemed to be a feature of AT1A receptors, as changes in osmolality did not affect binding to BK B2 receptors. These findings support our hypothesis that binding of Ang II to RMIC is dependent on the osmolality of the surrounding fluid and that this receptor binding dependency on osmolality is completely reversible. Although this phenomenon did not seem to apply to all receptors (BK receptors were unaffected), there has also been a report of osmolality-induced changes of ET binding. Reduction in binding of ET to cultured RMIC was observed under hyperosmolal conditions (4). However, unlike Ang II, ET binding in the kidney is observed traversing regions of both low and high osmolality. These distributions are subtype dependent, with binding to the ETA receptor subtype being restricted to regions of low osmolality (11). Interestingly, we found that only the ETA receptor subtype is retained in RMIC cultured from the whole medulla (17), but it is likely that ETB receptors could be retained if the osmolality of the medium is increased. Such a mechanism would appear be different from that observed for AT1A receptors.
The examination of Ang II receptor mRNA was carried out in an attempt to dissect out the mechanisms that govern the osmotically sensitive change in Ang II binding to RMIC. The presence of mRNA for AT1A receptors was observed in RMIC regardless of the osmolality of the medium in which they were incubated. Similarly, occurrence of mRNA for the BK B2 receptor was found to be independent of osmolality. Although the present study did not set out to quantitate changes in the amount of receptor protein with osmolality, estimates of receptor numbers derived from the competition binding assays indicate that the reduction of Ang II binding (after increased osmolalities) was not due to decreases in receptor numbers. To the contrary, the data are consistent with an increase in receptor number but decreased affinity with increases in osmolality. The decreased affinity of the receptor for its ligand could be explained through osmotically induced alterations in the tertiary structure of the receptor protein. A study that reported a change in the conformational state of the AT1 receptor leading to its inactivation supports this hypothesis (19). Although the current study made no attempt to measure the binding of internalized ligand separate from the cell surface bound ligand, studies are being performed to investigate whether receptor internalization plays a role in the osmolality-dependent receptor binding mechanism.
Thus, the present study suggests that the mechanism by which reduced Ang II binding occurs in hyperosmolal environments is not mediated at the transcriptional level but could be due to changes in the receptor protein structure. However, other mechanisms known to be involved in the regulation of osmotically sensitive systems may also play a role. For example, the activity of aldose reductase (an enzyme responsible for sorbitol synthesis and involved with intracellular organic osmolyte accumulation) increases in hyperosmotic conditions as a result of increases in both mRNA and protein synthesis (20,21). It has also been reported that Ang II AT1 receptor mRNA are likely to form hairpin loop-like structures that can interact with RNA binding proteins. AT1 5' leader sequence binding proteins have been identified, and their activity is regulated by deoxycorticosterone acetate (22). These binding proteins or their interaction with the AT1 mRNA may also be sensitive to changes in osmotic conditions, thus providing an additional level of receptor expression control.
In summary, the current study provides evidence to support the importance of osmolality in the regulation of AT1A receptor activity on RMIC. Although the mechanism underlying this phenomenon is unlikely to involve modulation of mRNA transcription, further studies are required to determine the precise mechanism of receptor regulation.
The study also provides a basis for examination of osmotically induced changes in receptor binding in vivo. We conclude that through osmotic regulation of AT1A receptors, RMIC may have an important role in determining renal responsiveness to Ang II.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. B. Burg, J. D. Ferraris, and N. I. Dmitrieva Cellular Response to Hyperosmotic Stresses Physiol Rev, October 1, 2007; 87(4): 1441 - 1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee, Z. Wu, K. Sandberg, S-E. Yoo, and C. Maric Posttranscriptional mechanisms contribute to osmotic regulation of ANG type 1 receptors in cultured rat renomedullary interstitial cells Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R44 - R49. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. McCulloch, R. Chambrey, D. Eladari, and J. Peti-Peterdi Localization of connexin 30 in the luminal membrane of cells in the distal nephron Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1304 - F1312. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Handa, S. E. Handa, and M. K. S. Elgemark Autoradiographic analysis and regulation of angiotensin receptor subtypes AT4, AT1, and AT(1---7) in the kidney Am J Physiol Renal Physiol, November 1, 2001; 281(5): F936 - F947. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |